Key statistics
On Friday, GlucoTrack Inc (GCTK:NAQ) closed at 1.65, 8.32% above its 52-week low of 1.52, set on Feb 06, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.66 |
|---|---|
| High | 1.70 |
| Low | 1.61 |
| Bid | 1.55 |
| Offer | 1.66 |
| Previous close | 1.63 |
| Average volume | 98.95k |
|---|---|
| Shares outstanding | 910.69k |
| Free float | 851.82k |
| P/E (TTM) | -- |
| Market cap | 1.50m USD |
| EPS (TTM) | -1,225.32 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Announcements
- Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
- Glucotrack, Inc. Encourages Shareholders to Vote
- Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
- Glucotrack, Inc. Reminds Shareholders to Vote
- Glucotrack to Participate in the Q3 Virtual Investor Summit
- Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
- Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
- Glucotrack Announces Repurchase of Series A Warrants
- Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
- Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
More ▼
